CompanyRACCNasdaqNew York, NY

Research Alliance Corp III

SEC EDGAR ClinicalTrials.gov doi.org

424B4Nov 4Latest SEC filing

Nov 9Latest story

November 2026

Ionis cuts Tryngolza 2026 sales guidance, highlights Zanvastro launch and new Phase 3 wins

Nov 9Quarterly updateIonis Pharmaceuticals olezarsenUpdated